LIPOCINE INC.

LPCN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $-21.0M $-19.0M $-18.2M $-20.4M $-10.6M $3.9M $-5.2K
Depreciation & Amortization $28.4K $32.0K $26.7K $14.6K $21.8K $42.6K
Depreciation
Amortization
Stock-Based Compensation $2.7M $2.4M $1.2M $1.9M $979.2K $127.5K
Net Cash from Operating Activities $-16.7M $-18.3M $-15.4M $-17.3M $-8.6M $-3.2M $-7.3K
Investing Activities
Capital Expenditures $0 $59.7K $28.7K $59.6K $1.2K $12.3K
Business Acquisitions
Net Cash from Investing Activities $3.1M $3.2M $-25.0M $-1.2K $-12.3K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $11.2M $605.9K $32.7M $48.5M $0 $30.2K
Net Change in Cash $-2.3M $-14.4M $-7.7M $-17.6M $39.9M $-3.2M $22.9K
Free Cash Flow $-16.7M $-18.3M $-15.4M $-17.4M $-8.6M $-3.2M
← Newer Page 2 of 2 Older →